Taiwanese hospital to install ZAP Surgical's radiosurgery platform
Kaohsiung Show Chwan Memorial Hospital (KSCH) is set to install ZAP Surgical Systems' ZAP-X Gyroscopic Radiosurgery platform, representing a major step forward in Taiwan's neuro-oncology landscape.
The installation, scheduled for the fourth quarter of 2025, will begin treating patients from the first quarter of 2026.
Part of the Show Chwan Healthcare System, KSCH is a new medical facility in Taiwan.
The hospital is enhancing its neuro-oncology practice with the ZAP-X system, which offers non-invasive treatment for patients with brain tumours and other neurological disorders.
SRS is a non-invasive, painless procedure that treats brain tumours and other head and neck disorders without incisions.
Typically completed in a single outpatient visit, SRS represents a significant departure from traditional open surgery.
Show Chwan Healthcare System president Dr. Min-Ho Huang said: 'SRS is revolutionising the way we treat brain tumours and neurological conditions.
'With the addition of ZAP-X at KSCH, we are reinforcing our commitment to providing world-class, non-invasive treatment solutions to patients in Taiwan and beyond.'
The integration of ZAP-X makes radiosurgery more accessible, removing the requirements for expensive shielded radiation rooms.
The ZAP-X platform uses a modern linear accelerator for radiation generation, avoiding the challenges of managing and replacing Cobalt-60 radioactive isotopes.
The gyroscopic design of the ZAP-X system allows for the precise targeting of tumours from thousands of angles, which helps to protect critical structures, such as the brain stem and optic nerves.
This precision reduces radiation exposure to healthy brain tissue, improving patient safety and preserving cognitive function.
The Show Chwan Healthcare System has traditionally used Cobalt-60 technology for SRS treatments.
The addition of the ZAP-X platform offers an alternative, promising to improve treatment versatility and accuracy.
"Taiwanese hospital to install ZAP Surgical's radiosurgery platform" was originally created and published by Hospital Management, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 days ago
- Yahoo
Scientists achieve 'world first' by heating plasma to multimillion degree temperatures: 'Helping to unlock the mysteries of the cosmos'
A research team in Germany recently achieved what it called "a world first in fusion research," exciting the clean energy community, Interesting Engineering reported. The research team is part of the world's largest stellarator facility, Wendelstein 7-X (W7-X), where scientists have been hard at work developing a more efficient way to generate fusion energy. And now, they've finally achieved their goal, generating high-energy helium-3 ions for the first time. Nuclear fusion is the process of using force to merge two atomic nuclei. The act of combining these nuclei results in a tremendous release of energy, which provides a great deal of power that can be used for everything from fuel alternatives to electricity on a commercial scale. Fusion is a clean and naturally occurring means of energy generation; in fact, it's the primary type of power and reaction that creates the stars. And it doesn't generate polluting emissions the way other fuel sources do, appealing to climate advocates. Therefore, the more we can scale our usage of fusion, the cleaner and less overheated our planet's atmosphere will be. For fusion to happen, the process must be made more efficient. Fusion occurs inside a superheated plasma, which is kept at multimillion-degree temperatures. Traditionally, this fusion results in high-energy "alpha particles" (helium-4 nuclei), but those particles can be prone to escape, which can cool the plasma and halt the entire process. That's why the team focused on generating smaller, lower-energy particles, which could maintain the fusion process in a more manageable way. They did this using ion cyclotron resonance heating (ICRH). As Interesting Engineering explained, ICRH entails sending electromagnetic waves into plasma at "the specific frequency at which helium-3 ions naturally orbit around the magnetic field lines" in order to help the particles absorb energy. "This is similar to pushing a child on a swing: to be effective, each push must be precisely in tune with the swing's natural frequency — in other words, it must be in resonance," the scientists wrote in their press release. "This is the first time that high-energy helium-3 ions have been produced in a stellarator using ion cyclotron resonance heating (ICRH): a world first in fusion research." Researchers highlighted how the findings will also help them better understand how the sun works, as these same resonance processes used at W7-X may occur in nature. "These findings show that fusion science is not only shaping the future, but also helping to unlock the mysteries of the cosmos around us," the press release concluded. Should we be pouring money into nuclear fusion technology? Yes — it'll pay off It's worth exploring Not from our tax dollars No — it's a waste Click your choice to see results and speak your mind. Join our free newsletter for weekly updates on the latest innovations improving our lives and shaping our future, and don't miss this cool list of easy ways to help yourself while helping the planet.
Business Upturn
3 days ago
- Business Upturn
Dr. Lal PathLabs boots genomics capabilities with Illumina's NovaSeq™ X Series
By Aman Shukla Published on June 25, 2025, 11:39 IST Dr. Lal PathLabs Limited (DLPL), one of India's most trusted names in diagnostics, has taken a major step forward in genomics by adding the advanced NovaSeq™ X Series from Illumina to its dedicated genomics unit, Genevolve. This cutting-edge technology allows DLPL to deliver faster and more accurate results in genetic research. The NovaSeq™ X system, powered by Illumina's XLEAP-SBS™ chemistry, offers top-notch performance with high speed, accuracy, and sustainability. In fact, the NovaSeq X Plus can handle over 20,000 whole genomes per year—twice as much as earlier models. Genevolve, launched in 2019, has quickly made a name for itself as a leader in DNA-based diagnostics and next-generation sequencing (NGS). With the new Illumina platform onboard, DLPL is now even better equipped to offer quick, AI-driven insights that can support smarter healthcare decisions. 'With the addition of Illumina's NovaSeq X Series, we are taking another step forward in driving innovation and scientific excellence,' said Shankha Banerjee, CEO, Dr. Lal PathLabs Limited. 'This investment allows us to broaden our capabilities and contribute meaningfully to India's evolving genomics landscape.' Looking ahead, Dr. Lal PathLabs and Illumina plan to work closely with India's medical and research communities to promote the use of genomics in healthcare, helping unlock new possibilities in personalized medicine. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Wire
19-06-2025
- Business Wire
ZAP Surgical Announces First ZAP-X Gyroscopic Radiosurgery
SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the first patient treatments using its ZAP-X® Gyroscopic Radiosurgery® platform in Latin America. Located in Neuland, Boquerón, Paraguay, Radioterapia Concordia ( has officially commenced clinical use, marking a major milestone in the decentralization of state-of-the-art brain tumor care across the region. In its first day of operation, four patients received next-generation stereotactic radiosurgery (SRS) with ZAP-X® for a range of intracranial conditions, including meningioma, acoustic neuroma, trigeminal neuralgia, and arteriovenous malformation (AVM). Historically, patients in the central regions of Latin America have had limited or no access to modern SRS, often requiring travel to large metropolitan hubs like Buenos Aires, São Paulo, or Santiago. Radioterapia Concordia now offers these advanced treatments locally, helping bridge a longstanding healthcare gap for rural communities. 'People in rural areas deserve to receive world-class medical care where they live, from people they understand, and at a fair price,' said Prof. Dr. Peter Douglas Klassen, Founder of Saludconcordia SA. 'With ZAP-X, we are bringing the most advanced SRS capabilities to communities that have long been underserved.' The creation of Radioterapia Concordia is further bolstered by its strategic location along the Bi-Oceanic Corridor—a transformative infrastructure project linking Brazil, Paraguay, Argentina, and Chile to improve regional access and trade. The new cancer center also benefits from its collaborative relationship with ZAP-X Zentrum Lingen in Germany, home to Europe's first ZAP-X system. 'This is more than just a technology deployment—it's a movement toward cooperative medicine,' said MBA MSc Edelgard Loewen, Case Manager at ZAP-X Zentrum Lingen. 'We're witnessing a new model emerge in Latin America—one that rises above the limitations of national and purely private healthcare systems to prioritize patients through altruistic, turnkey cancer care.' As an alternative to open brain surgery, stereotactic radiosurgery is a non-invasive, outpatient procedure used to treat many primary and metastatic brain tumors, as well as other disorders of the head and neck. Unlike traditional surgery however, SRS does not require incisions or anesthesia, and patients often return to normal activities the same day. The ZAP-X system is renowned for its unique gyroscopic design, which enables the delivery of radiosurgical beams from thousands of unique angles. This approach enhances the ability to concentrate radiation precisely on the tumor while minimizing dose to surrounding healthy brain tissue—an important factor in preserving cognitive function. ZAP-X is also the first and only vault-free SRS system, removing the need for costly shielded treatment rooms. Additionally, by utilizing a modern linear accelerator, ZAP-X eliminates the use of Cobalt-60, avoiding the exorbitant costs and regulatory burdens tied to radioactive isotopes. For more information about ZAP Surgical and the ZAP-X system, visit About ZAP Surgical Systems, Inc. ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X® Gyroscopic Radiosurgery® platform. ZAP was founded in 2014 by Dr. John R. Adler, Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife ® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60. Learn more at ZAP Surgical and follow us on LinkedIn.
